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depletion (adjusted change = –0.2, 95% CI: –0.6, 0.2). No ev-
idence of association was observed between maternal se-
rum transferrin receptor level and its ratio to ferritin with in-
fant PWV. Maternal anaemia (<11 g/dl) at  ≤ 20 weeks’ gesta-
tion was associated with a 1.0-m/s increase in infant PWV 
(adjusted 95% CI: 0.1, 1.9).  Conclusion: This is the largest 
study to date which has assessed peripheral PWV as a mea-
sure of arterial stiffness in infants. There was no evidence of 
an association between markers of maternal iron status ear-
ly in pregnancy and infant PWV.  © 2015 S. Karger AG, Basel 
 Introduction 
 Arterial stiffness in adults has been shown to be an in-
dependent predictor of cardiovascular events  [1] . It has 
also been linked with childhood indicators of cardiovas-
cular risk  [2, 3] . Increased arterial stiffness leads to faster 
return of the reflected pulse wave from peripheral sites to 
the left ventricle, and hence suboptimal ventricular-arte-
rial interaction  [4] . Measurement of pulse wave velocity 
(PWV) is accepted as the most simple, convenient and 
reproducible method to determine arterial stiffness over 
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 Abstract 
 Background: In animal studies, iron deficiency during preg-
nancy has been linked to increased offspring cardiovascular 
risk. No previous population studies have measured arterial 
stiffness early in life to examine its association with mater-
nal iron status.  Objective: This study aimed to examine the 
association between maternal iron status in early pregnan-
cy with infant brachio-femoral pulse wave velocity (PWV). 
 Methods: The Baby VIP (Baby’s Vascular Health and Iron in 
Pregnancy) study is a UK-based birth cohort which recruited 
362 women after delivery from the Leeds Teaching Hospitals 
postnatal wards. Ferritin and transferrin receptor levels were 
measured in maternal serum samples previously obtained in 
the first trimester. Infant brachio-femoral PWV was mea-
sured during a home visit at 2–6 weeks.  Results: Iron deple-
tion (ferritin <15 μg/l) was detected in 79 (23%) women in 
early pregnancy. Infant PWV (mean = 6.7 m/s, SD = 1.3, n = 
284) was neither associated with maternal ferritin (adjusted 
change per 10 μg/l = 0.02, 95% CI: –0.01, 0.1), nor with iron 
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the life course  [1] . PWV is determined by dividing the dis-
tance of the pulse travel between two sites by the transit 
time, and is inversely related to arterial distensibility  [4] .
 Iron deficiency (ID) is the leading single nutrient de-
ficiency in the world. Maternal ID anaemia has been 
linked to risk of low birth weight, preterm delivery and 
infant ID anaemia  [5] . There is experimental evidence 
supporting the involvement of maternal ID in the pro-
gramming of adult hypertension and obesity. In pregnant 
rats, ID results in increased risk of offspring obesity and 
hypertension  [6] . Postulated mechanisms include in-
creased placental cytokine and tumour necrosis factor 
levels, and altered metabolism of mediators of cell func-
tion and metals such as copper  [7] . ID can also induce 
changes in placental structure including decreased capil-
lary length and surface area and increased placental vas-
cularisation, and may interfere with fetal kidney develop-
ment and nephron number  [8] .
 Few studies have examined the relationship between 
maternal nutritional exposures and childhood arterial 
stiffness  [9–11] . To our knowledge, there are no popula-
tion studies assessing such relationships with neonatal or 
infant arterial stiffness. However, it has been shown that 
PWV measurements can be reliably ascertained in new-
borns with good reproducibility  [12, 13] .
 The aim of this study was to investigate the relation-
ship between maternal iron status early in pregnancy with 
offspring arterial stiffness at 2–6 weeks of life.
 Materials and Methods 
 Study Design and Population 
 The Baby VIP (Baby’s Vascular Health and Iron in Pregnancy) 
study is a birth cohort study. It comprises women aged  ≥ 18 years 
who gave birth at the Leeds Teaching Hospitals Trust Maternity 
Unit at a gestational age of  ≥ 34 weeks between February 2012 and 
January 2013. The participants were recruited from the postnatal 
wards after delivery. Those who agreed to take part were asked if 
the research team could contact them after they were discharged 
home to arrange a home visit within 6 weeks.  Figure 1 illustrates 
the participant flowchart. Ethical approval was obtained from the 
 Fig. 1. Participant flowchart. 
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South Yorkshire Committee of the NHS National Research Ethics 
Service (11/YH/0064). All procedures were in accordance with the 
1975 Helsinki Declaration as revised in 1983.
 Outcome Measurement 
 Brachio-femoral PWV (bfPWV) was measured using the Vi-
corder device (Skidmore Medical), which uses an oscillometric 
technique. This kit provides a non-invasive method of measuring 
PWV, and is thought to be relatively independent of operator skills 
 [14] . Two infant-size cuffs were used. The arm cuff was wrapped 
around the bare skin of the baby’s arm, with the mid cuff point 
halfway between the shoulder and the elbow. The leg cuff was 
wrapped around the bare skin of the baby’s ipsilateral thigh with 
the mid cuff point halfway between the groin and the knee. Using 
a tape measure, the distance was measured in centimetres between 
the two marked points in a straight line while keeping the baby’s 
thigh straight, with the tape kept on the internal side of the arm 
alongside the trunk. The pressure applied was 35 mm Hg for both 
the arm and the leg. The pulse recording at the two arterial sites 
was obtained simultaneously. Transit time was measured as the 
time delay between the feet of the proximal and the distal pulse 
waves. A minimum of two PWV readings was obtained from each 
baby. If they were more than 0.3 m/s different, a third reading was 
obtained. The average of all available readings for each baby was 
used in the analyses.
 Exposure Measurement 
 Serum ferritin (sF) is the most widely used biomarker in the 
assessment of iron status. The ratio of serum transferrin receptor 
(sTfR) to sF (R/F) is considered the gold standard marker of iron 
status  [15] , and has been used to assess iron status in pregnant 
populations  [16] . Maternal serum samples of 348 women, previ-
ously stored during the first trimester of pregnancy as part of 
routine antenatal care, were analysed. sF was measured using 
ELISA (Demeditic, Kiel, Germany). 10 μl of plasma were treated 
with a sandwich ELISA method, using fluorometric measure-
ments and calibrated using standards supplied by the manufac-
turer. Quality controls were included as appropriate. The WHO 
cutoff of 15 μg/l in sF was used to indicate depleted iron stores 
 [17] .
 sTfR assays were performed using a commercially available kit 
based on a polyclonal antibody in a sandwich enzyme immuno-
assay format (DTFR1; R&D Systems, Minneapolis, Minn., USA). 
This yielded sTfR levels in nmol/l units. The values were converted 
to μg/l using a molecular weight of sTfR of 75,000 Da (R&D tech-
nical data sheet). The R/F ratio was obtained by dividing sTfR over 
sF (μg/l:μg/l). This was logged to obtain normal distribution.
 Maternal haemoglobin (Hb) values were extracted from the an-
tenatal care records and/or the hospital electronic results server. A 
cutoff of 11 g/dl in Hb was used to indicate anaemia at  ≤ 20 weeks’ 
gestation, and 10.5 g/dl to indicate anaemia beyond 20 weeks’ ges-
tation, following the UK National Institute for Health and Care 
Excellence guidelines  [18] .
 Covariable Assessment 
 The Index of Multiple Deprivation (IMD) was derived using 
the GeoConvert tool utilising the UK census data (geoconvert.mi-
mas.ac.uk). Birth weight, gestational age, parity, maternal height, 
weight, ethnicity, smoking, pregnancy complications (pre-ec-
lampsia, gestational diabetes), blood pressure measurements and 
intake of iron supplements were extracted from the clinical rec-
ords. Infant heart rate was recorded by the Vicorder device with 
each PWV measurement.
 Statistical Methods 
 Statistical analysis was performed using Stata version 11 (2009; 
College Station, Tex., USA). Customised birth weight centile was 
calculated taking into account gestational age, maternal height, ma-
ternal pre-pregnancy or booking weight, ethnicity, parity, and neo-
natal sex  [19] . Univariable analysis was performed using an inde-
pendent sample t test, one-way analysis of variance or Mann-Whit-
ney test for continuous variables, and χ 2 test for categorical variables.
 Multiple linear regression was performed with PWV as the 
main outcome, and indicators of maternal iron status as predic-
tors. The models were adjusted for baby covariables at birth (cus-
tomised birth weight centile) and at measurement (age, position, 
measurement side, arousal state and type of feeding), and maternal 
covariables including age, smoking status, the presence of gesta-
tional diabetes or pre-eclampsia, blood pressure at booking and at 
36 weeks’ gestation, and IMD deprivation score. Sensitivity analy-
ses were performed taking into account the intake of iron supple-
ments during pregnancy and infant heart rate at the time of PWV 
measurements.
 Sample Size Calculation 
 For a difference of 0.3 m/s in PWV between iron-deficient and 
non-iron-deficient mothers, using a mean of 4.7 m/s, a standard 
deviation (SD) of 0.6 m/s and a prevalence of ID of 20%, a sample 
size of 265 mother-baby pairs was required to achieve 90% power 
with p = 0.05  [12] .
 Table 1.  Infant bfPWV in relation to measurement conditions and 
infant characteristics in the Baby VIP study
Infant bfPWV, m/s
n m ean SD p
Sleeping status <0.001a
Asleep 48 5.9 1.1
Awake 239 6.8 1.3
Position during measurement <0.001b
In mother’s arms 121 6.5 1.3
Feeding in mother’s arms 101 7.2 1.2
In cot/on sofa or floor 61 6.1 1.1
Measurement side 0.2a
Right 98 6.8 1.4
Left 181 6.6 1.2
Baby’s age 0.7a
<28 days 206 6.6 1.3
≥28 days 77 6.7 1.4
Type of feeding 0.06b
Breast 122 6.9 1.4
Bottled 109 6.5 1.3
Mixed 53 6.4 1.2
 a Independent samples t test. b One-way analysis of variance.
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 Results 
 We recruited 362 mother-baby pairs, with 284 (79%) 
babies going on to have PWV measurements at home. 
Mean infant bfPWV was 6.7 m/s (SD = 1.3). The mean 
difference in PWV between the first and the second 
measurement was –0.02 m/s (95% CI: –0.16, 0.11, Bland-
Altman limits of agreements: –2.3 to 2.2 m/s). The with-
in-subject coefficient of variation was 1.3% and the in-
traclass correlation coefficient was 0.6 (95% CI: 0.5–
0.7). The difference between the first and second PWV 
measurement was 0.3 m/s or less in 31% and 0.5 m/s or 
less in 49% of the babies. Mean baby age at the time of 
measurement was 25 days (SD = 6).  Table 1 describes 
infant PWV in relation to measurement conditions
and baby characteristics. The baby being asleep was, on 
average, associated with a 0.9-m/s reduction in infant 
bfPWV (95% CI: 0.5, 1.3).  Table 2 describes the charac-
teristics of participants with or without PWV measure-
ments.
 Median sF was 31.7 μg/l [interquartile range (IQR): 
16.9–62.4]. 79 women (23%) women had depleted iron 
stores. The median sTfR was 12.8 nmol/l (IQR: 10.2–
16.1). Mean maternal Hb was 12.6 g/dl and 11.6 g/dl
(SD = 1.0) in the first and second halves of pregnancy, 
respectively. The prevalence of anaemia at  ≤ 20 weeks’ 
(<11 g/dl) and >20 weeks’ gestation (<10.5 g/dl) was 5% 
(16/329) and 14% (48/337), respectively. Only half of the 
anaemic women in the first half (n = 8) and 45% of the 
anaemic women in the second half of pregnancy (n = 22) 
had a first trimester sF of less than 15 μg/l. 121 women 
(34%) took iron supplements during pregnancy: 8 (2%) 
started in the first trimester compared to 67 (19%) in the 
second and 46 (13%) in the third trimester.
 There was no evidence of association between infant 
bfPWV and maternal sF (adjusted change in PWV in m/s 
per 10-μg/l change in sF = 0.02, 95% CI: –0.01, 0.1, p = 
0.3), nor with maternal iron depletion (adjusted change 
in PWV in m/s = –0.2, 95% CI: –0.6, 0.2, p = 0.3). No 
evidence of association was observed between maternal 
sTfR or log R/F with infant bfPWV. However, anaemic 
mothers in the first half of pregnancy (Hb <11 g/dl) had 
infants with higher PWV by 1.0 m/s on average (95% CI: 
0.1, 1.8, p = 0.02;  table 3 ).
 Table 2.  Characteristics of participants in the Baby VIP study (n = 362) according to whether babies were followed up by home visits to 
measure PWV after hospital recruitment
With PWV measurements  Without PWV measurements pa
total
n
mean ± SD/
n (%)/median
95% CI/IQR tot al
n
mean ± SD/
n (%)/median
95% CI/IQR
Gestational age, days 284 277 ± 14 78 276.3 ± 14 0.5
Birth weight, g 284 3,339 ± 636 78 3,293 ± 621 0.6
Maternal age at antenatal booking, years 284 31.1 ± 5.5 78 28.6 ± 6.0 0.0007
Maternal BMI at antenatal booking 281 26.5 ± 6.1 77 25.3 ± 4.9 0.1
IMD 284 28.6 ± 19.1 78 32.7 ± 19.6 0.1
Maternal Hb at ≤20 weeks’ gestation, g/dl 263 12.6 ± 1.0 66 12.4 ± 1.2 0.1
Maternal Hb at >20 weeks’ gestation, g/dl 266 11.6 ± 1.0 71 11.4 ± 1.1 0.2
First-trimester maternal sF, μg/l 273 33.4 17.4 – 61.6 75 28.6 13.1 – 68.7 0.5
First-trimester maternal sTfR, nmol/l 273 13.1 10.4 – 16.1 75 12.3 10.1 – 16.1 0.6
First-trimester maternal R/F ratio, μg/l 273 27.5 15.3 – 61.9 75 32.0 14.0 – 72.9 0.6
Primiparous 284 144 (51) 45 , 57 78 29 (37) 27 , 49 0.03
Male baby 284 137 (48) 42 , 54 78 45 (58) 47 ,  69 0.1
Maternal White ethnicity 284 220 (78) 72 , 82 78 68 (87) 78 , 94 0.1
Maternal smoking at antenatal booking 278 36 (13) 9 , 18 76 13 (17) 9 , 28 0.5
Gestational diabetes 284 5 (2) 1 , 4 78 1 (1) 0 , 7 0.1
Pre-eclampsia 284 3 (1.1) 0  , 3.1 78 3 (3.9) 1.0 , 10.8 0.1
Anaemia at ≤20 weeks’ gestation (<11 g/dl) 263 10 (4) 2 , 7 66 6 (9) 3 , 19 0.1
Anaemia at >20 weeks’ gestation (<10.5 g/dl) 266 35 (13.2) 9.3 , 1.8 71 13 (18.3) 10.1 , 29.3 0.3
Had taken iron supplements in pregnancy 284 92 (32) 27 , 38 77 29 (38) 27 , 49 0.4
Had taken multivitamin supplements in pregnancy 284 157 (55) 49 , 61 77 32 (42) 30 , 53 0.03
a Independent samples t test or Mann-Whitney test for continuous variables, and χ2 test for categorical variables.
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 No association was observed between maternal intake 
of iron supplements at any stage in pregnancy and infant 
PWV (unadjusted change = –0.1, 95% CI: –0.5, 0.2). Ad-
justing for iron supplement intake did not alter the results 
of the models examining the association between mater-
nal iron biomarkers with infant bfPWV, while it strength-
ened the association between maternal anaemia in early 
pregnancy and infant PWV (adjusted change = 1.2 m/s, 
95% CI: 0.3, 2.1). Adjusting for infant heart rate attenu-
ated the association between early pregnancy maternal 
anaemia and infant PWV (adjusted change = 0.4 m/s, 
95% CI: –0.7, 1.4, p = 0.5).
 Discussion 
 PWV, a potential marker of cardiovascular health lat-
er in life, was ascertained in 284 babies aged 2–6 weeks at 
home in the Baby VIP study. We found no association 
between maternal iron status biomarkers in early preg-
nancy and infant PWV. However, maternal anaemia in 
the first half of pregnancy was associated with increased 
infant PWV.
 The elastic properties of arteries vary along the arte-
rial tree, with more elastic proximal arteries and stiffer 
distal ones. The amplitude of the pressure wave is higher 
in peripheral arteries than in central arteries. This ‘ampli-
fication phenomenon’ is known to be more pronounced 
in younger subjects  [1] . In adults, average brachio-ankle 
PWV is approximately 20% higher than carotid-femoral 
PWV  [20] . These reasons may explain the relatively high-
er bfPWV average in our study compared to the average 
newborn aortic PWV reported elsewhere  [12, 21] . An-
other explanation could also be the way the distance was 
assessed between the two arterial sites (in a straight line). 
This is likely to be shorter than the distance the pulse 
wave travels along the vessel.
 The ability of PWV measured very early in life to pre-
dict later cardiovascular health is unknown. Although 
there was no evidence of association with maternal iron 
status, this does not exclude the possibility that the latter 
may be linked to offspring cardiovascular indicators in 
adulthood. Therefore, long-term follow-up of a birth co-
hort with information on maternal iron status in preg-
nancy is required.
 We found an association between early pregnancy ma-
ternal anaemia and infant arterial stiffness. Anaemia 
could reflect the extreme of the ID spectrum; however, 
only half of the anaemic women had sF <15 μg/l. Anoth-
er study by the authors found no evidence of association 
between early pregnancy maternal Hb and offspring 
PWV at 10 years  [22] . Maternal anaemia may have a true 
effect on infant arterial function, which may subside later 
in life. Alternatively, the observed association could be 
due to residual confounding by other causes of maternal 
poor health.
 In a sensitivity analysis, we adjusted for infant heart 
rate in the association between maternal anaemia and in-
fant PWV. This can improve the precision of the estimate 
if heart rate is strongly linked to the outcome. However, 
it cannot be considered a true confounder as it cannot af-
fect maternal anaemia. Therefore, it was not included in 
the main model. Some studies have found heart rate to 
have a significant effect on arterial stiffness, while others 
have not  [23–26] . Infant heart rate could potentially be a 
mediator in the relationship between maternal anaemia 
 Table 3.  Associations of infant bfPWV at 2 – 6 weeks with indicators of iron status during pregnancy in the Baby VIP study
Predictor  Change in infant bfPWV (m/s)
un-
a djusted
95% CI p ad-
justeda
adjusted
95% CI
p n (multi-
variable model)
Maternal sF at 12 weeks’ gestation (per 10-μg/l change) 0.02  – 0.01, 0.1 0.2 0.02  – 0.01, 0.1 0.3 261
Maternal iron depletion at 12 weeks’ gestation (sF <15 μg/l) –0.2  – 0.5, 0.3 0.4 –0.2  – 0.6, 0.2 0.3 261
Maternal sTfR at 12 weeks’ gestation (nmol/l) 0.03 –0.004, 0.1 0.1 0  – 0.01, 0.04 0.3 261
Maternal log R/F ratio at 12 weeks’ gestation (μg/l) 0  – 0.1, 0.1 0.9 0  – 0.2, 0.1 0.5 261
Maternal Hb at ≤20 weeks’ gestation (g/dl) 0.1  – 0.1, 0.3 0.3 0.1  – 0.1, 0.2 0.6 253
Maternal Hb at >20 weeks’ gestation (g/dl) 0.2 –0.001, 0.3 0.05 0.2 –0.004, 0.3 0.06 256
Maternal anaemia at ≤20 weeks’ gestation (<11 g/dl) 0.7  – 0.1, 1.6 0.08 1.0   0.1, 1.9 0.02 253
Maternal anaemia at >20 weeks’ gestation (<10.5 g/dl) –0.1  – 0.5, 0.4 0.8 0.01  – 0.5, 0.5 0.9 256
 a Adjusted for baby’s age, PWV measurement circumstances (position, feeding, asleep or awake, side), maternal age, smoking, gestational diabetes, pre-
eclampsia, blood pressure at booking and 36 weeks’ gestation, deprivation score, and customised birth weight centile (takes into account maternal pre-preg-
nancy weight, height, ethnicity, parity, gestational age and baby’s sex).
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and infant PWV if it is postulated that anaemic mothers 
are more likely to give birth to anaemic babies. However 
in this study, although infant heart rate was inversely as-
sociated with PWV, it was not associated with maternal 
anaemia (data not shown).
 Our study assessed the exposure of interest prospec-
tively, as the maternal serum samples were collected in 
the first trimester of pregnancy. We used the best avail-
able measure for iron status – the R/F ratio which relates 
directly to total body iron stores  [15] . We assessed PWV, 
an innovative measure of cardiovascular health which 
causes less distress than measuring blood pressure in ne-
onates/young infants, on a relatively large study popula-
tion compared to other studies which have assessed PWV 
in this age group  [12, 21] . Information on maternal Hb 
and iron supplements was ascertained objectively from 
the medical records, rather than by self-reporting.
 A potential source of error in measuring PWV is the use 
of more distal conduit sites as a surrogate for less accessible 
central arteries  [4] . However, the forearm circulation is 
where blood pressure is commonly measured, and lower 
limb arteries are commonly altered by atherosclerosis  [1] . 
Estimating the actual distance between the recording sites 
using surface measurements could also be a source of er-
ror. The shorter the distance, the greater the absolute error 
in determining transit time  [1] . However, our PWV data 
spread corresponds well with most other studies. Further-
more, any errors in measuring the distance between the 
arterial sites would be non-differential as the researcher 
was blind to the exposure. A further limitation is that we 
did not record infant blood pressure in this study.
 This study demonstrates that infant arterial stiffness 
can be assessed using non-invasive techniques in popula-
tion studies. Further research is needed to investigate the 
relationship between maternal nutrition during pregnan-
cy and PWV in the child and adult offspring using a pro-
spective study design to investigate the potential path-
ways underlying the developmental origins of cardiovas-
cular disease.
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